On Wednesday, Tableau Software Inc (NYSE:DATA)’s shares inclined 0.89% to $103.07.
PostUp, a leading digital and email marketing solution company, declared recently the availability of its Email Strategy solution, a planned offering in partnership with Tableau Software ( DATA) and Return Path.
PostUp’s Email Strategy solution empowers email marketers with the ability to easily understand vast amounts of data through the use of clear visuals so that they can determine what is working in their email strategies (in addition to those of their competitors) within one platform.
Tableau Software, Inc., together with its auxiliaries, provides business analytics software products in the United States, Canada, and internationally. The company offers Tableau Desktop, a self-service analytics environment that empowers people to access and analyze data independently; and Tableau Server, a business intelligence platform with data administration, scalability, and security to foster the sharing of data, in addition to improve the dissemination of information in an organization and promote improved decision-making.
PVH Corp (NYSE:PVH)’s shares dropped -1.18% to $112.33.
SPEEDO USA, a division of PVH Corp. (PVH), declared that five-time Olympic medalist, holder of two individual world records and competitive swimming superstar Missy Franklin has joined Team Speedo, marking her first endorsement since becoming a professional swimmer in March 2015. As part of Team Speedo, Franklin will serve as a year-round brand ambassador, sharing her love of the water to inspire others, and will wear Speedo race suits when she represents the US at all major competitions globally.
PVH Corp. operates as an apparel company in the United States and internationally. It designs, markets, and retails men’s and women’s apparel and accessories, branded dress shirts, neckwear, sportswear, jeanswear, intimate apparel, swim products, handbags, footwear, golf apparel, fragrances, cosmetics, eyewear, hosiery, socks, jewelry, watches, outerwear, small leather goods, and home furnishings, in addition to other related products.
At the end of Wednesday’s trade, Royal Gold, Inc USA) (NASDAQ:RGLD)‘s shares surged 3.68% to $54.65.
Royal Gold, Inc. (RGLD) provides an operational update for its streaming and royalty interests at Mount Milligan, Phoenix and Voisey’s Bay, in addition to an update on the status of its streaming transaction with Golden Star Resources Ltd. (“Golden Star”) and its Peak Gold Joint Venture (“Peak Gold”).
For the quarter ended June 30, 2015, the Company’s wholly owned partner, RGLD Gold AG (“RGLD Gold”), purchased about 21,400 ounces of gold from the Mount Milligan mine at a cash price of $435 per ounce as part of its purchase and sale agreement with Thompson Creek Metals Company, Inc. (“Thompson Creek”), and sold about 23,000 ounces of gold related to Mount Milligan. In addition, RGLD Gold had about 5,300 ounces remaining in inventory as of June 30, 2015.
Royal Gold, Inc., together with its auxiliaries, acquires and manages precious metals royalties, metal streams, and similar interests. It focuses on acquiring royalty interests or to finance projects that are in production or in development stage in exchange for royalty interests.
Alkermes Plc (NASDAQ:ALKS), ended its Wednesday’s trading session with -0.13% loss, and closed at $67.88.
Alkermes Plc (ALKS) stated financial results for the second quarter of 2015.
Quarter Ended June 30, 2015 Highlights
- Total revenues for the quarter were $151.4 million contrast to $153.4 million for the same period in the preceding year. The preceding year period comprised of $21.1 million of revenues from the products associated with the Gainesville manufacturing facility that was divested in April 2015.
- Net loss according to generally accepted accounting principles in the U.S. (GAAP) was $46.1 million, or a basic and diluted GAAP loss per share of $0.31, for the quarter. This contrast to GAAP net income of $3.7 million, or a basic GAAP earnings per share (EPS) of $0.03 and a diluted GAAP EPS of $0.02, for the same period in the preceding year, which comprised of GAAP net income of $7.3 million related to the Gainesville facility and associated products and $27.6 million of net income from two one-time transactions.
Alkermes Public Limited Company, an integrated biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in various therapeutic areas. The company offers RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia schizoaffective disorder; AMPYRA/FAMPYRA to treat multiple sclerosis; BYDUREON to treat type II diabetes; and VIVITROL for alcohol and opioid dependence.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
